NIH has revised its renewal policy from three strikes to "two strikes and you're out." Currently funded projects will be grandfathered to allow three attempts for continued funding but they won't accept any -A2 applications after January 7, 2011. 1st try: R01AA012345-06 2nd try: R01AA012345-06A1 3rd try: R01AA012345-06A2 (NLT 7 Jan 11) Robert Aull Indiana University New NIH Policy on Resubmission (Amended) Applications ---------------------------------------------------------------------------- Notice Number: NOT-OD-09-003 Key Dates Release Date: October 8, 2008 Issued by National Institutes of Health (NIH), (http://www.nih.gov) Purpose NIH announces a change in the existing policy on resubmission (amended) applications (see http://grants.nih.gov/grants/policy/amendedapps.htm). Beginning with original new applications (i.e., never submitted) and competing renewal applications submitted for the January 25, 2009 due dates and beyond, the NIH will accept only a single amendment to the original application. Failure to receive funding after two submissions (i.e., the original and the single amendment) will mean that the applicant should substantially re-design the project rather than simply change the application in response to previous reviews. It is expected that this policy will lead to funding high quality applications earlier, with fewer resubmissions. Background Following the release of the Peer Review Report that was drafted with extensive consultation with the external community, Dr. Zerhouni, NIH Director, established a Peer Review Oversight Committee (PROC) to finalize the recommendations and begin immediate implementation of those recommendations. Of particular concern was the marked reduction in the number of awards made in response to original applications. An increasing number of projects were funded only after one or more resubmissions. In periods of constricted funding, a greater number of projects require resubmission, and review committees are more likely to show greater preference for amended applications. These trends have increased the time from original submission to award and the number of submissions per investigator. As a result, there has been greater burden placed on applicants and reviewers as well as a delay in funding for meritorious science. To change this trend and increase the likelihood that meritorious original applications will be funded, the NIH will decrease the number of amendments allowed. Accordingly, the NIH will begin to phase out second amendment applications starting with the January 25, 2009 due date. This policy will increase the numbers of high quality original and first amendments that can be funded earlier. NIH Policy on Resubmission (Amended) Applications Beginning with applications intended for the January 25, 2009 due date, all original new applications (i.e., never submitted) and competing renewal applications will be permitted only a single amendment (A1). For this and subsequent cohorts of original new and competing renewal applications, any second amendment (A2) will be administratively withdrawn and not accepted for review. Applicants who fail to receive funding after two submissions may resubmit but only if the application is fundamentally revised to qualify as new. A new application is expected to be substantially different in content and scope with more significant differences than are normally encountered in an amended application. Note that there is no time limit for the submission of the original and subsequent A1. Original new and competing renewal applications that were submitted prior to January 25, 2009 will be permitted two amendments (A1 and A2). For these "grandfathered" applications, NIH expects that any A2 will be submitted no later than January 7, 2011, and NIH will not accept A2 applications after that date. This policy applies to all applications, including applications submitted under the NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, Career Development Awards, Individual Fellowships, Institutional Training Grants, Resource Grants, Program Projects, and Centers. Currently no amendments are permitted for applications received in response to a Request for Applications (RFA) unless it is specified in the Funding Opportunity Announcement, in which case only one amendment will be permitted. ations (RFA) unless it is specified in the Funding Opportunity Announcement, in which case only one amendment will be permitted. Inquiries Applicants are strongly encouraged to discuss their questions with their NIH IC contact. For additional information or questions, please contact: Division of Receipt and Referral Center for Scientific Review 6701 Rockledge Drive MSC 7720 Bethesda, MD 20892-7720 Voice: (301) 435-0715 Fax: (301) 480-1987 Or send an email to xxxxxx@mail.nih.gov. Clinicalmail is a service provided by the Association of American Medical Colleges ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================
